Abstract
Kawasaki disease (KD), an acute febrile vasculitis, is the most common cause of acquired heart disease in infants and young children. However, the diagnosis of infantile KD can be difficult or delayed due to vague clinical manifestations. This current study aimed to assess the clinical characteristics and cardiac complications of infantile KD. The study retrospectively reviewed the data of 242 patients with KD. The clinical, laboratory, and echocardiographic data between infants and older children were analyzed. The patients were divided into two groups: infants 12 months old or younger and children older than 12 months. The rate of incomplete KD was much more frequent in infants. During all phases, prohormone brain natriuretic peptide (Pro-BNP) levels were higher in infants, as was thrombocytosis. The coronary artery z-score was higher in infants at all phases of KD. On tissue Doppler imaging, the E/E′ ratio (ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity) was higher at the septal and lateral annulus in infants. Infant patients with KD are at increased risk for the development of coronary abnormalities and diastolic dysfunction. Higher levels of Pro-BNP and thrombocytosis with diastolic echo parameters of a higher E/E′ ratio can help to identify incomplete KD in infants.
Similar content being viewed by others
References
Burns JC, Wiggens JW, Toews WH et al (1986) Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 109:759–763
Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH (2006) Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 25:241–244
Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C et al (2009) Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 30:810–817
Elaine AR, Kathleen EC, Stanford TS (1995) Kawasaki disease in infants less than one year of age. J Pediatr 126:524–529
Hsiao JY, Chen MR, Huang FU, Kao HA, Sung TC (1998) Clinical analysis of Kawasaki disease in infants below 6 months of age. Acta Paediatr Sin 29:318–323
Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248
Kim SH, Kim KH, Kim DS (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:580–590
Lee HJ, Kim HJ, Kim HS, Sohn SJ (2006) NT-pro BNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 49:539–544
Limbach HG, Lindinger A (1991) Das Kawasaki-Syndrom bei Sauglingen im ersten Lebanshalbjahr. Klin Padiatr 203:133–136
McCrindle B, Li J, Minich L, Colan S, Atz A, Takahashi M et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179
Melish ME (1996) Kawasaki syndrome. Pediatr Rev 17:153–162
Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD (1989) Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma-globulin. Circulation 79:1237–1246
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Am Heart Assoc 114:1708–1733
Nigrovic LiseE, Nigrovic PeterA, Harper MB, Chiang VW (2006) Extreme thrombocytosis predict Kawasaki disease in infants. Clin Pediatr 45:446–452
Rowley AH, Gonzalez-Crussi F, Shulman ST (1991) Kawasaki syndrome. Curr Probl Pediatr 21:387–405
Sato YZ, Molkara DP, Daniels LB et al (2011) Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 142:103–110
Selamet Tierney ES, Newburger JW, Graham D, Baker A, Fulton DR, Colan SD (2011) Diastolic function in children with Kawasaki disease. Int J Cardiol 148:309–312
Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG (1987) Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 141:420–425
Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K et al (1996) Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 155:291–296
Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387–394
Takeuchi D, Saji T, Takatsuki S, Fujiwara M (2007) Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 71:357–362
Yellen ES et al (2010) Performance of 2004 American heart association recommendations for treatment of Kawasaki disease. Pediatrics 125:234–241
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
No, S.J., Kim, D.O., Choi, K.M. et al. Do Predictors of Incomplete Kawasaki Disease Exist for Infants?. Pediatr Cardiol 34, 286–290 (2013). https://doi.org/10.1007/s00246-012-0440-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-012-0440-3